|
INVESTIGATIVE
UROLOGY
Protein
oxidation as a novel biomarker of bladder decompensation
Kalorin CM, Mannikarottu A, Neumann P, Leggett R, Weisbrot J, Johnson
A, Kogan BA, Levin RM
Albany Medical College, Albany, NY, USA
BJU Int. 2008; 102: 495-9
- Objective:
To
measure the degree to which partial bladder outlet obstruction (PBOO)
results in oxidative bladder damage, which subcellular components of
the bladder are affected and whether these changes correlate with bladder
function.
-
Materials and Methods:
In all, 32 rabbits were divided into four groups. Each group underwent
PBOO for 1, 2, 4, and 8 weeks, respectively. Bladder tissue from each
group was homogenized and separated into subcellular fractions via differential
centrifugation. The carbonyl content within the subcellular fractions,
including the nuclear, mitochondrial, and microsomal pellets, was then
quantified by dot blot analysis.
-
Results:
Total bladder oxidation increased with duration of obstruction across
all subcellular fractions. The largest increase in total oxidation occurred
between 4 and 8 weeks. Protein oxidation density in the nuclear and
microsomal fractions both showed increases at 2 weeks obstruction, decreases
at 4 weeks, and then large increases at 8 weeks. The increase in protein
oxidation density between 4 and 8 weeks obstruction was most pronounced
in the microsomal fraction.
-
Conclusions: Overall
bladder protein oxidation increased with the duration of obstruction
and increased at a greater rate during the transition to decompensation.
Furthermore, the subcellular fraction that exhibited the most oxidation
was the microsomal pellet. The amount of protein oxidation correlated
with the functional changes in the bladder.
- Editorial
Comment
In this interesting and welcome experimental study, the authors created
surgically partial bladder outlet obstruction (PBOO) in 32 rabbits.
They were interested to analyze whether oxidative stress measured after
PBOO would correlate with the function of the bladder and whether markers
of oxidative stress might serve as a biomarker of the progression to
bladder decompensation.
The authors presented clear evidence that protein oxidation occurs to
a significant degree in the PBOO rabbit bladder. They concluded that
overall bladder protein oxidation increases with the duration of obstruction
and increases at a greater rate during the transition to full decompensation.
They speculated that in the clinical setting, the urologist could obtain
tissue from the bladder of a patient with BPH and analyze it specifically
for microsomal protein oxidation and determine the degree to which the
patient is moving towards decompensation. Of course, theoretically,
it could be done, but probably it will be hard to put in clinical use.
The authors are to be congratulated for this elegant study that opens
new avenue for the understanding and management of benign prostatic
hyperplasia consequences.
Dr.
Francisco J. B. Sampaio
Full-Professor and Chair, Urogenital Research Unit
State University of Rio de Janeiro
Rio de Janeiro, RJ, Brazil
E-mail: sampaio@urogenitalresearch.org |